ROSEN Law Firm Advocates for Gritstone bio Investors Before Securities Class Action Deadline

NEW YORK, July 08, 2024 — ROSEN, a globally recognized law firm, is issuing a reminder to investors who purchased securities from Gritstone bio, Inc. GRTS during the period of March 9, 2023, to February 29, 2024. The firm advocates for shareholders to seek qualified counsel before the impending deadline of August 6, 2024, concerning an ongoing securities class-action lawsuit.

Gritstone bio, Inc. Profile

Gritstone bio, Inc., situated in Emeryville, California, operates as a pioneering clinical-stage biotechnology entity. The company's endeavors are concentrated on formulating personalized cancer immunotherapies with a target-specific approach designed to combat a broad spectrum of cancers as well as infectious diseases.

Details of the Securities Class Action

Investors who acquired shares of Gritstone bio, Inc. GRTS during the designated class period and suffered losses, have till the stated deadline to seek a position as a lead plaintiff. The lawsuit alleges that the company may have issued materially misleading business information to the investing public. The lead plaintiff will act on behalf of other class members in directing the Gritstone bio class-action lawsuit.

Investor Actions and Next Steps

ROSEN Law Firm is urging investors who have experienced substantial losses from their investment in Gritstone bio securities during the specified timeframe to contact the firm to acquire legal representation. Interested parties are encouraged to secure counsel before the critical August deadline. This reminds all investors of the significance of acting in a timely manner to ensure their rights are fully protected.

Rosen, Law, Deadline, Lawsuit, GRTS, Investors, Securities